Skip to main content

3 Reasons CGNX is Risky and 1 Stock to Buy Instead

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CGNX Cover Image

What a time it’s been for Cognex. In the past six months alone, the company’s stock price has increased by a massive 68.1%, reaching $64.18 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Is there a buying opportunity in Cognex, or does it present a risk to your portfolio? Get the full breakdown from our expert analysts, it’s free.

Why Is Cognex Not Exciting?

We’re happy investors have made money, but we’re sitting this one out for now. Here are three reasons you should be careful with CGNX, plus one stock we’d rather own.

1. Long-Term Revenue Growth Disappoints

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Over the last five years, Cognex grew its sales at a tepid 3.5% compounded annual growth rate. This fell short of our benchmark for the business services sector.

Cognex Quarterly Revenue

2. EPS Trending Down

Analyzing the long-term change in earnings per share (EPS) shows whether a company’s incremental sales were profitable — for example, revenue could be inflated through excessive spending on advertising and promotions.

Sadly for Cognex, its EPS declined by 2.2% annually over the last five years while its revenue grew by 3.5%. This tells us the company became less profitable on a per-share basis as it expanded.

Cognex Trailing 12-Month EPS (Non-GAAP)

3. New Investments Fail to Bear Fruit as ROIC Declines

A company’s ROIC, or return on invested capital, shows how much operating profit it makes compared to the money it has raised (debt and equity).

We like to invest in businesses with high returns, but the trend in a company’s ROIC is what often surprises the market and moves the stock price. Over the last few years, Cognex’s ROIC has unfortunately decreased. We like what management has done in the past, but its declining returns are perhaps a symptom of fewer profitable growth opportunities.

Cognex Trailing 12-Month Return On Invested Capital

Final Judgment

Cognex isn’t a terrible business, but it doesn’t pass our bar. Following the recent rally, the stock trades at 43.3× forward P/E (or $64.18 per share). This valuation tells us a lot of optimism is priced in - we think other companies feature superior fundamentals at the moment. Let us point you toward one of Charlie Munger’s all-time favorite businesses.

Stocks We Would Buy Instead of Cognex

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  250.02
-6.50 (-2.53%)
AAPL  310.26
-4.94 (-1.57%)
AMD  542.52
+20.98 (4.02%)
BAC  52.40
-0.08 (-0.15%)
GOOG  355.68
-2.71 (-0.76%)
META  622.98
+25.35 (4.24%)
MSFT  427.34
-13.97 (-3.17%)
NVDA  214.75
-8.07 (-3.62%)
ORCL  230.33
-14.25 (-5.83%)
TSLA  423.70
-0.04 (-0.01%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.